• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蒽环类药物诱导的心脏毒性:临床病程、危险因素、发病机制、检测与预防——文献综述

Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature.

作者信息

Wojtacki J, Lewicka-Nowak E, Leśniewski-Kmak K

机构信息

Department of Radiotherapy, Polish Red Cross Marine Hospital, Gdynia-Redłowo, Poland.

出版信息

Med Sci Monit. 2000 Mar-Apr;6(2):411-20.

PMID:11208348
Abstract

Anthracycline antibiotics are widely used antineoplastic agents and their efficacy for the treatment of various haemopoietic or solid tumours has been well established in clinical practice. Cardiotoxicity is one of the most serious side effects of anthracyclines. The risk of cumulative, life-threatening toxic cardiomyopathy limits their therapeutic potential. In this article, acute, subacute, chronic and late-onset cardiac function impairment associated with anthracycline administration has been characterised. The current views on the methods of detection, pathogenesis and prevention of such toxicity have been reviewed.

摘要

蒽环类抗生素是广泛使用的抗肿瘤药物,其在治疗各种血液系统或实体肿瘤方面的疗效已在临床实践中得到充分证实。心脏毒性是蒽环类药物最严重的副作用之一。累积性、危及生命的毒性心肌病风险限制了它们的治疗潜力。在本文中,已对与蒽环类药物给药相关的急性、亚急性、慢性和迟发性心功能损害进行了特征描述。已对目前关于此类毒性的检测方法、发病机制和预防的观点进行了综述。

相似文献

1
Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature.蒽环类药物诱导的心脏毒性:临床病程、危险因素、发病机制、检测与预防——文献综述
Med Sci Monit. 2000 Mar-Apr;6(2):411-20.
2
[Cardiotoxicity of anthracyclines].[蒽环类药物的心脏毒性]
Ann Med Interne (Paris). 1984;135(6):464-72.
3
[Cardiotoxicity of anthracyclines].[蒽环类药物的心脏毒性]
Rev Med Chir Soc Med Nat Iasi. 2011 Oct-Dec;115(4):1200-7.
4
Pathogenesis and prevention of doxorubicin cardiomyopathy.阿霉素心肌病的发病机制与预防
Tsitologiia. 1997;39(10):928-37.
5
Exposure to anthracyclines during childhood causes cardiac injury.儿童时期接触蒽环类药物会导致心脏损伤。
Semin Oncol. 2006 Jun;33(3 Suppl 8):S8-14. doi: 10.1053/j.seminoncol.2006.04.019.
6
Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.辅酶Q10预防蒽环类药物所致心脏毒性
Integr Cancer Ther. 2005 Jun;4(2):110-30. doi: 10.1177/1534735405276191.
7
[Cardioprotection in women with neoplastic disease].[肿瘤疾病女性患者的心脏保护]
G Ital Cardiol (Rome). 2012 Jun;13(6):461-8. doi: 10.1714/1073.11765.
8
Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.蒽环类化疗后实体瘤患儿的晚期心脏评估
Pediatr Blood Cancer. 2005 Apr;44(4):370-7. doi: 10.1002/pbc.20281.
9
Anthracycline-induced cardiomyopathy.蒽环类药物诱导的心肌病。
Postgrad Med. 2008 Nov;120(4):67-72. doi: 10.3810/pgm.2008.11.1940.
10
Cardiac toxicity after anthracycline chemotherapy in childhood.儿童蒽环类化疗后的心脏毒性。
Herz. 2000 Nov;25(7):676-88. doi: 10.1007/pl00001982.

引用本文的文献

1
The Gut-Heart Axis and Its Role in Doxorubicin-Induced Cardiotoxicity: A Narrative Review.肠道-心脏轴及其在多柔比星诱导的心脏毒性中的作用:一篇叙述性综述。
Microorganisms. 2025 Apr 9;13(4):855. doi: 10.3390/microorganisms13040855.
2
Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer.中性粒细胞生物标志物可预测蒽环类药物在乳腺癌中的心脏毒性。
Int J Mol Sci. 2024 Sep 9;25(17):9735. doi: 10.3390/ijms25179735.
3
A Systematic Review of the Cardiotoxic Effects of Targeted Therapies in Oncology.肿瘤靶向治疗心脏毒性作用的系统评价
Cureus. 2024 Aug 6;16(8):e66258. doi: 10.7759/cureus.66258. eCollection 2024 Aug.
4
Liraglutide Pretreatment Does Not Improve Acute Doxorubicin-Induced Cardiotoxicity in Rats.利拉鲁肽预处理不能改善大鼠急性多柔比星诱导的心脏毒性。
Int J Mol Sci. 2024 May 27;25(11):5833. doi: 10.3390/ijms25115833.
5
Anthracycline-Induced Cardiomyopathy in Cancer Survivors: Management and Long-Term Implications.癌症幸存者中的蒽环类药物所致心肌病:管理与长期影响
Adv Exp Med Biol. 2025;1474:179-199. doi: 10.1007/5584_2024_804.
6
Doxorubicin-induced cardiotoxicity and risk factors.多柔比星诱导的心脏毒性及危险因素。
Int J Cardiol Heart Vasc. 2023 Dec 27;50:101332. doi: 10.1016/j.ijcha.2023.101332. eCollection 2024 Feb.
7
Evaluation of acute toxicity and in vitro antitumor activity of a novel doxorubicin-loaded folate-coated pH-sensitive liposome.新型载多柔比星叶酸靶向 pH 敏感脂质体的急性毒性评价及体外抗肿瘤活性研究。
Biomed Pharmacother. 2023 Sep;165:115280. doi: 10.1016/j.biopha.2023.115280. Epub 2023 Aug 2.
8
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?蒽环类药物诱导的心脏毒性:靶向高密度脂蛋白以限制损伤?
Lipids Health Dis. 2022 Sep 1;21(1):85. doi: 10.1186/s12944-022-01694-y.
9
Doxycycline Attenuates Doxorubicin-Induced Cardiotoxicity by Improving Myocardial Energy Metabolism in Rats.多西环素通过改善大鼠心肌能量代谢减轻阿霉素诱导的心脏毒性。
J Cardiovasc Dev Dis. 2022 Aug 8;9(8):254. doi: 10.3390/jcdd9080254.
10
Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis.化疗所致心脏毒性的潜在基因关联研究:一项系统评价与荟萃分析
Front Cardiovasc Med. 2021 Jun 4;8:651269. doi: 10.3389/fcvm.2021.651269. eCollection 2021.